期刊文献+

应用荧光原位杂交技术检测膀胱尿路上皮癌的研究 被引量:5

The use of fluorescence in situ hybridization in the detection of urothelial bladder cancer
原文传递
导出
摘要 目的比较荧光原位杂交技术(FISH)与尿液脱落细胞学在膀胱尿路上皮癌检测中的灵敏性与特异性,评估FISH在中国人群中筛查膀胱尿路上皮癌的作用。方法 2007年12月至2008年6月,收取20例健康志愿者的新鲜尿液,应用荧光标记的3号、7号、17号染色体着丝粒探针及p16位点探针,在尿液标本中的脱落细胞上进行FISH检测,建立正常人群的阈值。其后留取无膀胱癌病史的119例血尿患者的尿液标本,膀胱镜检查前同期行尿液脱落细胞学检查及FISH检测。对比尿液脱落细胞学检查及FISH检测结果,对FISH、尿液脱落细胞学检查检测膀胱尿路上皮癌的敏感性和特异性采用McNemar配对卡方检验进行统计学分析。结果 3号、7号和17号染色体非整倍性改变及p16位点异常的正常阈值分别为1.0%、2.0%、1.0%和2.0%。对血尿患者进行的FISH、尿液脱落细胞学检测膀胱尿路上皮癌总的敏感性分别为83.1%(54/65)和52.3%(34/65)(P<0.001)。对于pTa~1期、pT2~4期肿瘤,FISH检测的敏感性分别为76.1%(35/46)和100.0%(19/19),而尿液脱落细胞学检查的敏感性分别为43.5%(20/46)和73.7%(14/19);对于低级别尿路上皮癌,FISH和尿液脱落细胞学的敏感性分别为72.2%(13/18)和5.6%(1/18),而对于高级别尿路上皮癌的敏感性分别为87.2%(41/47)和70.2%(33/47)。FISH检测、脱落细胞学检查的特异性分别为92.6%(50/54)、94.4%(51/54)(P=1.0)。FISH检测膀胱尿路上皮癌的敏感性明显优于尿液脱落细胞学检查,而两者的特异性并无统计学意义。结论 FISH技术能明显提高膀胱尿路上皮癌的筛查率,尤其是早期和低级别病变,可以成为筛查膀胱尿路上皮癌的一种新的无创性检查方法。 Objective We determine the relative sensitivities and specificities of cytology and fluorescence in situ hybridization(FISH) for the detection of urothelial bladder cancer in order to evaluate the clinical utility of FISH in the screening of urothelial bladder cancer.Methods From December 2007 to June 2008,the fresh urine voided by 20 healthy volunteers was obtained.A mixture of fluorescently labeled Probes were targeted to the chromosomes 3,7and 17 and p16.FISH was performed on exfoliated urothelial cells in the urine to get the threshold value of healthy adult.Urine voided by 119 patient with hematuria was collected and examined by cytology and FISH simultaneously before cystoscopy.No history of bladder cancer is required.The McNemar test was used to determine the statistical significance between the yields of the different tests.Results The threshold value of chromosomes 3,7 and 17 and p16 were 1.0%,2.0%,1.0% and 2.0% respectively.FISH affords an overall sensitivity of 83.1%(54 /65),the figure being 76.1%(35/46) for pTa ~ 1,100%(19 /19) for pT2 ~ 4 tumors.The sensitivities of cytology were 43.5%(20 /46) for pTa ~ 1,73.7%(14 /19) for pT2 ~ 4 tumors,with an overall sensitivity of 52.3%(34 /65) .The sensitivitiesof the two methods for the low grade tumors were 72.2%(13 /18) and 5.6%(1 /18),and for high grade tumors were 87.2%(41 /47) and 70.2%(33 /47),respectively.The specificities of FISH and cytology were 92.6%(50 /54) and 94.4%(51 /54),respectively(P = 1.0) .Conclusions According to the results,the sensitivity of FISH for the detection of urothelial bladder cancer is superior to that of cytology,and the specificities of FISH and cytology are not significantly different.FISH can improve markedly the screening rate of urothelial bladder cancer,especially for the low stage and low grade tumors,and will be a new noninvasive screening method for urothelial bladder cancer.
出处 《中华临床医师杂志(电子版)》 CAS 2010年第7期976-980,共5页 Chinese Journal of Clinicians(Electronic Edition)
基金 卫生部科研基金课题(WKJ2007-3-001)
关键词 泌尿系肿瘤 原位杂交 荧光 细胞诊断学 Urologic neoplasms In situ hybridization,fluorescence Cytodiagnosis
  • 相关文献

参考文献13

  • 1虞颂庭;臧美孚;夏溟.尿路上皮肿瘤概论,2004.
  • 2Theodorescu D.Molecular pathogenesis of urothelial bladder cancer,2003(01).
  • 3Phillips JL;Richardson IC.Aneuploidy in bladder cancers:the utility of fluorescent in situ hybridization in clinical practice[J],2006(01).
  • 4Parkin DM;Bray F;Ferlay J.Global cancer statistics,2002[J]CA:A Cancer Journal for Clinicians,2005(02):74-108.
  • 5Messing EM;Young TB;Hunt VB.Comparison of bladder cancer outcome in men undergoing hematuna home screening versus those with standard clinical presentations,1995(03).
  • 6Amira N;Mourah S;Rozet F.Non-invasive molecular detection of bladder cancer recurrence[J],2002(03).
  • 7Glas AS;Roos D;Deutekom M.Tumor markers in the diagnosis of primary bladder cancer:a systematic review[J],2003(06).
  • 8Sarosdy MF;Kahn PR;Ziffer MD.Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria[J],2006(01).
  • 9Marin-Aguilera M;Mengual L;Ribal MJ.Utility of a multiprobe fluores-cence in situ hybridization assay in the detection of superficial urothelial bladder cancer[J],2007(02).
  • 10Varella-Garcia M;Akduman B;Sunpaweravong P.The UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancer[J],2004(01).

二级参考文献24

  • 1穆大为,周利群,丁义,何志嵩,王莹,何群,杨新宇.应用荧光原位杂交技术检测膀胱尿路上皮癌的研究[J].中华临床医师杂志(电子版),2010,4(7):976-980. 被引量:5
  • 2Hailing KC,,Kipp BR.Bladder cancer detection using FISH(UroVysion Assay). Advances in Anatomic Pathology . 2008
  • 3徐文坚,(德)SebastianLange.泌尿系统影像诊断学[M]人民卫生出版社,2003.
  • 4Roy JY,,Staekel GA,Ayala AG.Cytologic and histologic features of superficial bladder cancer. Urologic Clinics of North America . 1992
  • 5Cianciulli A M,Leonardo C,Guadagni Fet al.Genetic instability in superficial bladder cancer and adjacent mucosa:an interphase cytogenetic study. Human Pathology . 2003
  • 6van Rhijin BW,,van der Poel HG,van der Kwast TH.Urine mark-ers for bladder cancer surveillance:a systematic review. European Urology . 2005
  • 7Sun M,,Abdo A,Abdollah F,et al.Management of upper urinary tract urothelial carcinoma. Expert Review of Anticancer Therapy . 2010
  • 8Skacel M,Fahmy M,Brainard JA,et al.Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. Journal d’Urologie . 2003
  • 9Stewart GD,Bariol SV,Grigor KM,Tolley DA,McNeill SA.A comparison of the pathology of transitional cell carcinoma of the bladder and upper urinary tract. BJU International . 2005
  • 10Chow HN,Tzai TS,Cheng HL,Chan SH,Lin JSN.Urinary cytodiagnosis: can it have a different prognostic implication than a diagnostic test. Urologia Internationalis . 1994

共引文献3

同被引文献48

  • 1卢杨.膀胱输尿管反流患者膀胱输尿管吻合术后再返流发生率及危险因素分析[J].中国误诊学杂志,2019(12):549-551. 被引量:1
  • 2丁一,刘朝东.尿脱落细胞的FISH检查在膀胱癌诊断及复发监测中的应用[J].医学信息(医学与计算机应用),2014,0(12):636-636. 被引量:1
  • 3张业贵,毕新刚,韩亚玲,蔡岩,徐昕,吴玉鹏,杨壹羚,马建辉,赵平,贾雪梅,王明荣.多色荧光原位杂交在膀胱尿路上皮癌诊断中的应用[J].癌症,2007,26(2):189-193. 被引量:27
  • 4Hailing KC, Kipp BR. Bladder cancer detection using FISH( UroVysion assay ) [ J ]. Adv Anat Patho1,2008,15 ( 5 ) :279 -286.
  • 5Lotan Y, Shariat SF, Sehmitz-Drager BJ, et al. Considerations on implementing diagnostic markers into clinical decision making in bladder cancer[J]. Urol Oneol,2010,28(4) :441-448.
  • 6Skaeel M, Fahmy M, Brainard JA, et al. Muhitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the ma- jority of patients with bladder cancer and atypical or negative urine cytology[ J]. J Uro1,2003,169 (6) :2101-2105.
  • 7Kruger S, Mess F, Bohle A, et al. Numerical aberrations of chromo- some 17 and the 9p21 locus are independent predictors of tumor re- currence in non-invasive transitional cell carcinoma of the urinary bladder[J]. Int J Oncol,2003,23( 1 ) :4148.
  • 8Inoue T, Sato K, Tsuchiya N, et al. Numeric aberrations of HER-2 and chromosome 17 detected by fluorescence in situ hybridization in urine-exfoliated ceils from patients with urothelial carcinoma [ J ]. Urology,2004,64 (3) :617-621.
  • 9Hailing KC,,Kipp BR.Bladder cancer detection using FISH(UroVysion Assay). Advances in Anatomic Pathology . 2008
  • 10徐文坚,(德)SebastianLange.泌尿系统影像诊断学[M]人民卫生出版社,2003.

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部